APA

Ulaner G. A., Hyman D. M., Lyashchenko S. K., Lewis J. S. & Carrasquillo J. A. (20180508). 89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer. : Clinical nuclear medicine.

Chicago

Ulaner Gary A, Hyman David M, Lyashchenko Serge K, Lewis Jason S and Carrasquillo Jorge A. 20180508. 89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer. : Clinical nuclear medicine.

Harvard

Ulaner G. A., Hyman D. M., Lyashchenko S. K., Lewis J. S. and Carrasquillo J. A. (20180508). 89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer. : Clinical nuclear medicine.

MLA

Ulaner Gary A, Hyman David M, Lyashchenko Serge K, Lewis Jason S and Carrasquillo Jorge A. 89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer. : Clinical nuclear medicine. 20180508.